Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 16, 2022
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award
Celebrating faculty and staff achievements
Beyond Ben Stiller’s advice: What the experts say about PSA screening
The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened
‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next
Pulmonologist Houghton joins Center
McGarry Houghton seeks answers to lung cancer's molecular basis, epidemiology
GI oncologist Coveler joins Center
Andrew Coveler adds cancer immunotherapy, translational research expertise to Clinical Research Division
Register for comprehensive oncology CME Sept. 17-20
Course will aid participants’ preparation for the medical oncology certification or recertification exam and increase proficiency in management of patients with malignant disorders
Study of Japanese atomic bomb survivors shows radiation exposure poses similar risk of first and second cancers
First large-scale study to assess how radiation influences risk of multiple cancers
Fred Hutchinson Cancer Research Center receives a pledge of $10 million to bolster immunotherapy research
Gift fosters research that harnesses the immune system to fight cancer
Patient's cloned T cells kill tumors
Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission
Center wins $2.2 million for solid-tumor research program
Life Sciences Discovery Fund grant will support phase 1 clinical-trials program to test novel therapies for solid tumors
Science Backgrounder: Nothing Small About "Mini-Transplants"
Developed at the Hutchinson Center, therapy uses minimal doses of radiation